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ABSTRACT
The aim of this research was to investigate antimicrobial and cytotoxic activity of Indonesian 
ascidians. Extracts prepared from the Indonesian ascidians namely Lissoclinum patella, 
Oxycoryna fascicularis, Didemnum molle and Botryllus schlosseri were assessed for anti-
microbial and cytotoxic properties. Antibacterial activity of the extracts was tested against 
two Gram-positive bacteria, viz. Bacillus subtilis ATCC 6633 and Staphylococcus aureus 
ATCC 25923, and three Gram-negative bacteria, viz. Escherichia coli ATCC 25922, 
Vibrio cholerae ATCC 14035 and Pseudomonas aeruginosa ATCC 101454 using the disk 
diffusion test. Antifungal activity was also tested against Candida albicans ATCC 10231 and 
Aspergillus niger ATCC 16404. The minimum inhibitory concentrations (MICs) of potential 
ascidian extracts were determined by the microdilution technique. Cytotoxicity of the extracts 
was assessed using the brine shrimp lethality bioassay. By comparing the inhibition zones in 
the disk diffusion test, the most active anti-bacterial activity against Gram-positive bacteria 
(S. aureus and B. subtilis) was found in the crude extracts of Oxycoryna fascicularis and 
Didemnum molle. Lissoclinum patella extract showed the highest activity against the Gram-
negative bacteria E. coli and V. cholerae. The LC50 values of the crude extracts of Lissoclinum 
patella, Didemnum molle, Botryllus schlosseri, and Oxycoryna fascicularis were 74.3, 97.2, 
114.7 and 132.9 μg/ml, respectively. In our study, the most promising species for anti-
microbial and cytotoxic properties were Lissoclinum patella and Didemnum molle.
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INTRODUCTION
The marine environment becomes a new focus of 
natural product drug discovery because of its relatively 
unexplored biodiversity compared to terrestrial 
environment (Malve, 2016). Available resources for 
pharmacy can be found in the coral reef communities 
such as algae, soft coral, sponge, ascidian, marine 
microorganism, etc (Abdillah et al., 2015; Deepa et 
al., 2017; Ramos et al., 2016). Bio-prospection of 
marine natural products is one of the main interest of 
pharmaceutical research such as antibacterial, antiviral, 
antifungal, cytotoxic activity (Castro-Carvalho et al., 
2017). 
Sessile filter-feeding chordates known as ascidians are an 
important structural component of coral reef communities. 
They populate marine ecosystems, whether in tropical, 
subtropical or temperate waters. Ascidians have been 
the source of a wide variety of secondary metabolites, 
some of which have physiological functions, mainly in 
defense against their natural predators (Joullié et al., 
2003; Paul et al., 1990; Pisut & Pawlik, 2002)northern 
Sulawesi (Indonesia. While research efforts in bioactive 
metabolites from marine ascidians are relatively recent, 
some chemical compounds from marine ascidians 
are being evaluated as antitumor agents in preclinical 
and clinical trials. The most prominent example of an 
ascidian-derived drug is trabectedin or ecteinascidin 
743 (ET-743, Yondelis®), an alkaloid isolated from the 
Caribbean ascidian Ecteinascidia turbinate.  This is the 
first marine-derived drug to be prescribed against soft 
tissue carcinoma (Cuevas & Francesch, 2009; Gordon et 
al., 2016; Menna, 2009). 
It has been demonstrated that 7% of the compounds 
isolated from ascidians are produced by symbiotic 
bacteria, leaving the exact biosynthetic source of the 
remaining 93% of described metabolites unknown 
(Schmidt & Donia, 2010; Tianero et al., 2015). Many 
anti-microbial compounds have been isolated from 
ascidians or ascidian-associated marine bacteria. 
Antibacterial activity was observed in brominated 
rubrolides isolated from an African ascidian Synoicum 
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globosum (Sikorska, Parker-Nance, et al., 2012). 
Peptidolipins, which are lipopeptide compounds 
produced by bacteria (Nocardia sp.) from the Florida 
Keys tunicate Trididemnum orbiculatum, showed 
activity against methicillin-sensitive Staphylococcus 
aureus (MSSA) and methicillin-resistant Staphylococcus 
aureus (MRSA) (Wyche et al., 2012).
In the present study, investigations were undertaken 
on marine invertebrates from coastal areas of the 
Indonesian archipelago, one of the world’s hotspots 
of marine biodiversity. We examined organic extracts 
from some of the most abundant marine ascidians in the 
Buton islands, Southeast Sulawesi, namely Lissoclinum 
patella, Oxycoryna fascicularis, and Didemnum molle. 
We also investigated crude extracts of the ascidian 
Botryllus schlosseri collected from Selayar Island, South 
Sulawesi, for their anti-microbial and cytotoxic effects. 
Using the disk diffusion assay, the anti-bacterial activity 
of ascidian extracts was tested against five human 
pathogenic bacteria, viz. Staphylococcus aureus (ATCC 
25923), Bacillus subtilis (ATCC 6633), Eschericia coli 
(ATCC 25922), Vibrio cholerae (ATCC 14035), and 
Pseudomonas aeruginosa (ATCC 10145). Antifungal 
activity was similarly tested against Candida albicans 
(ATCC 10231) and Aspergillus niger (ATCC 16404). We 
also used the brine shrimp lethality bioassay to test for 
cytotoxic activity.
MATERIALS AND METHODS
Ascidian Sample Collection and Extraction
Three ascidians, Lissoclinum patella, Oxycoryna 
fascicularis, and Didennum molle, were collected in July 
2016 at a depth of 1-5 m by scuba diving from two sites 
of the Buton Islands, Southeast Sulawesi, Indonesia.  The 
ascidian Botryllus schlosseri was collected in June 2015 
at a depth of 5-10 m from Selayar Island, South Sulawesi 
(Table 1). A voucher record of each specimen (ASC1-
BT, ASC2-BT, ASC3-BT, ASC1-SLY) was deposited 
at the Research Center for Oceanography of Indonesian 
Institute of Science. Each ascidian sample of 150-200 
g wet weight was cut into small pieces, homogenized 
and extracted three times with MeOH-CHCl3 (3:1) 
at room temperature overnight. Following this, the 
crude extracts were concentrated by evaporation under 
reduced pressure. 
Antimicrobial Assays
Disk Diffusion Assay
Antibacterial activity of the ascidian extracts was 
assessed using the agar disk diffusion test6. Five 
reference strains of human pathogens were used in the 
assays, viz. two Gram-positive bacteria (Staphylococcus 
aureus ATCC 25923, Bacillus subtilis ATCC 6633) and 
three Gram-negative bacteria (Eschericia coli ATCC 
25922, Vibrio cholerae ATCC 14035, Pseudomonas 
aeruginosa ATCC 10145).  The bacteria were grown 
in liquid marine broth medium for 24 hours at room 
temperature. The various ascidian extracts were adjusted 
to a concentration of 100 µg/mL in MeOH and 20 μl of 
each extract was pipetted on to a sterile paper disk (6 
mm diameter) and allowed to dry.  A reference control 
paper disk carried 10 µg ampicillin in 20 μl MeOH.  The 
paper discs were then placed on Mueller Hinton Agar 
(Himedia) in a petri dish that had been inoculated with 
the test bacteria (107 CFU/mL). The inhibition zone that 
appeared was recorded after 24 h incubation at 30°C. All 
the assays were carried out in triplicate.
Candida albicans ATCC 10231 and Aspergillus niger 
ATCC 16404 were used as test fungi and inoculated on 
to Sabouraud Dextrose Agar (fungus) plates (104 CFU/
mL).  The various ascidian extracts were adjusted to a 
concentration of 100 µg/mL and 20 μl of each extract was 
pipetted on to 6 mm sterile paper disks. The discs were 
allowed to dry and then placed on Sabouraud Dextrose 
Agar. The inhibition zone was recorded after incubation 
at room temperature (25 °C) for 48 h. Nystatin (30 mg/
disc) was used as the positive control and methanol as 
the solvent control.  All the assays were performed in 
triplicate.
Microdilution Method
The microdilution method was used to evaluate the 
Table 1. Ascidians Species and Place of Collection
Sponge Species Depth (m) Place of Collection Voucher Specimen Number
Lissoclinum patella 1-5 m Buton Island (Southeast 
Sulawesi)
ASC1-BT 
Oxycoryna fascicularis 1-5 m Buton Island (Southeast 
Sulawesi)
ASC2-BT,
Didennum molle 1-5 m Buton Island (Southeast 
Sulawesi)
ASC3-BT
Botryllus schlosseri 5-10 m Selayar Island (South Su-
lawesi)
ASC1-SLY
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minimum inhibitory concentration (MIC) of the ascidian 
extracts which displayed high activity (growth inhibition 
halos more than 9 mm.) Tests were performed in 96-well 
round bottom sterile culture plates using the Infinite® 
200 PRO microplate reader (Tecan Austria GmbH). 
The assay plates were filled with Mueller-Hinton broth 
medium (MHB) containing different concentrations 
(62.5, 125, 250, 500 µg/ml) of Lissoclinum patella 
extract, Oxycoryna fascicularis extract, Didemnum molle 
extract, ampicillin or solvent control, as well as the test 
microorganism (107 CFU/mL).  After a 24 h incubation 
period at 37 °C, the turbidity in each well was measured 
at 600 nm. 
MIC for fungal strains was also performed using the 96-
well plate. Each well contained potato dextrose broth, 
different concentrations of Lissoclinum patella estract, 
Didemnum molle extract, Nystatin or solvent control, as 
well as the test yeast strain (104 CFU/mL). Incubation 
was performed at room temperature (18-20 °C) for 48 
h. The yeast growth was measured at 494 nm using the 
Infinite® 200 PRO microplate reader (Tecan Austria 
GmbH).
Brine Shrimp Lethality Bioassay
Different concentrations (10, 100, 1000 mg/ml) of the 
ascidian crude extracts were prepared for cytotoxic 
activity test using the brine shrimp lethality bioassay. 
Brine shrimp eggs (Artemia salina) were placed in a 
hatching tank containing 1 L of seawater under aeration 
at room temperature to hatch under continuous light. 
After 24 h, ten brine shrimp larvae were placed in 
a small container filled with sea water and different 
concentrations of the extracts. Survivors (instar III/
IV stage) were calculated after 48 h incubation, and 
the mortality percentage for each concentration and 
the control (seawater) was determined. Treatments and 
controls were prepared in triplicates.
Statistical Analysis
Measurements in all the experimental analyses were 
expressed as mean ± SD (n = 3). Results of the research 
were tested for statistical significance with One-way 
ANOVA. Differences were considered statistically 
significant at the P < 0.05 level. The statistical software 
package SPSS v.16 (SPSS Inc., Chicago, IL, USA) was 
used for the analysis.
RESULTS AND DISCUSSION
Antimicrobial Properties
The results of the agar disk diffusion assay on the crude 
ascidian extracts against five bacteria (Staphylococcus 
aureus ATCC 25923, Bacillus subtilis ATCC 6633, 
Escherichia coli ATCC 25922, Vibrio cholerae ATCC 
14035, Pseudomonas aeruginosa ATCC 10145) and 
two strains of fungus (Candida albicans ATCC 10231 
and Aspergillus niger ATCC 16404) are presented in 
Table 2. All the ascidian extracts showed potential anti-
microbial activities against at least one of the test strains. 
By comparing the inhibition zones, the most active anti-
bacterial activity against Gram-positive bacteria (S. 
aureus and B. subtilis) was shown for the crude extracts 
of Oxycoryna fascicularis and Didemnum molle. Against 
S. aureus, Oxycoryna fascicularis and Didemnum 
molle produced inhibition zones of 9.10 and 9.20 mm, 
respectively. Moreover, against B. subtilis, Oxycoryna 
fascicularis and Didemnum molle showed inhibition 
zones of 9.20 and 10.2 mm, respectively.
Lissoclinum patella extract was found to possess the 
highest activity against Gram-negative bacteria (E. 
coli and V. cholerae), with inhibition zones of 9.20 
and 9.1 mm, respectively. All ascidian extracts showed 
moderate activity against the Gram-negative bacterium 
P. aeruginosa. Based on the results from the anti-fungal 
assays, Didemnum molle demonstrated the highest 
Table 2. Antimicrobial Activity of Marine Ascidian Extracts Determined by the Disk Diffusion Assay
Species
Inhibition Zone (mm)
S. aureus B. subtilus E. coli V. cholerae P. aerugi-nosa C. albicans A. niger
Lissoclinum 
patella 6.80 7.50 9.20 9.10 3.30 4.8 4.3
Oxycoryna 
fascicularis 9.10 9.20 8.00 4.60 2.10 5.2 5.8
Didemnum 
molle 9.2 10.2 8.1 8.5 5.3 9.1 4.2
Botryllus 
schlosseri 8.60 7.30 0 3.60 4.50 3.7 4.1
Ampicillina 30.60 18.8 29.30 23.9 23.5 - -
Nystatina - - - 20.3 15.4
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Table 3. Minimum Inhibitory Concentrations (MICs in µg/ml) of Marine Ascidian Extracts
Ascidian 
extracts
Microorganisms
S. aureus B. subtilus E. coli V. cholerae P. aeruginosa C. albicans A. niger
Lissoclinum 
patella - - 250 250
- - -
Oxycoryna 
fascicularis 125 250 250 -
- - -
Didemnum 
molle 250 125 - -
- 250 -
Table 4. Effect of the Extract of Sponges on Brine Shrimp Survival
Acidians LC50 (μg/mL) Regression Equation R2
Lissoclinum patella 74.336 y = 5,3818x - 5,0702 R² = 0.9915
Oxycoryna fascicularis 132.91 Y = 1,6445 + 1.5078 R2 = 0.8028
Didemnun molle 97.145 y = 5,5812x - 6,0923 R² = 0.9281
Botryllus schlosseri 114.709 y = 3,9699x - 3,1765 R² = 0.9714
inhibitory activity against C. albicans, with an inhibition 
zone of 9.1 mm. MICs were determined for the three 
ascidian extracts that gave the best results for anti-
bacterial and anti-fungal activities.  Results from the 
broth microdilution method are summarized in Table 3.
Cytotoxic Activity
Cytotoxic activity of the ascidian extracts was evaluated 
using the brine shrimp lethality bioassay.  The LC50 
values of the crude extract of Lissoclinum patella, 
Oxycoryna fascicularis, Didemnum molle and Botryllus 
schlosseri were 74.3, 132.91, 97.145 114.71 μg/ml, 
respectively (Figure 1, Table 4). Based on the results 
from the cytotoxic assay, extracts of Lissoclinum patella 
and Didemnum molle were the most promising from the 
standpoint of cytotoxic activity. 
A large number of natural compounds, especially those 
with anti-microbial or cytotoxic properties, have been 
extracted from marine invertebrates. Among such marine 
invertebrates widely studied are the ascidians, from 
Figure 1. The Plot of Log Concentration of Crude 
Ascidian Extracts vs. Percent of Shrimp Mortality 
After 48 H of Exposure (Probits)
which a broad range of interesting bioactive compounds, 
including those showing anti-bacterial, anti-cancer, 
anti-inflammatory and antimalarial properties, have 
been extracted. Nonetheless, information on potential 
pharmacological characteristics of Indonesian ascidians 
remains rare. With the evolution of multiple resistance 
among pathogenic microorganisms, the search for 
new anti-microbials from alternative sources such as 
the marine environment has taken on a new urgency. 
We have, accordingly, initiated a program to screen 
Indonesian marine ascidians for anti-microbial and 
cytotoxic compounds.
Previous anti-microbial screenings have shown Gram-
positive bacteria to be more sensitive than Gram-negative 
bacteria or fungi to extracts of marine invertebrates such 
as sponges, and ascidians (Qaralleh et al., 2010; Tadesse 
et al., 2008) including the bacteria Staphylococcus 
aureus ATCC25923, Bacillus cereus ATCC11778, 
Pseudomonas aeruginosa ATCC27853, Escherichia coli 
ATCC35218, the yeasts Candida albicans ATCC10231 
and Cryptococcus neoformans ATCC90112. All the 
sponge species in this study showed antibacterial 
activity against at least one bacterial strain and only 
one sponge species was significantly active against C. 
albicans. P. aeruginosa was considered resistant to all 
tested samples, since no inhibition zone was observed 
while the Gram-positive B. cereus was shown to be the 
most sensitive microorganism followed by C. albicans 
and S. aureus. The highest activity was obtained for 
the aqueous extract of Neopetrosia exigua against the 
Gram-positive bacteria B. cereus (inhibition zone 25mm 
and MIC 0.07mg/mL. Our results that find the tested 
Karim, et al.
69
ISSN 2407-2354
Antimicrobial and Cytotoxic Properties Pharm Sci Res, Vol 5 No 2, 2018
extracts showing high activity against Gram-positive 
bacteria are, therefore, in agreement with these findings. 
Based on these results, extracts from two ascidians, 
viz. Lissoclinum patella and Didemnum molle, were 
found to be especially promising in their anti-bacterial 
action towards Gram-positive bacteria, whereas another 
ascidian Oxycorina fascicularis was reactive against 
Gram-negative bacteria. Didennum molle appears to 
have the greatest potential as an anti-microbial source. 
This ascidian was reactive against the Gram-positive 
bacteria (S. aureus and B. subtilis) and a fungal pathogen 
C. albicans. The anti-microbial activities of the extract 
from the genus Didemnum might be due to the presence 
of the compounds, Didemnoline A, Didemnoline C or 
Didemnaketal F, that are reported to be inhibitory to S. 
aureus, B. subtilis and C. albican (Palanisamy et al., 
2017; Schumacher & Davidson, 1999; Shaala et al., 
2014) while didemnolines B (2. The extract from another 
ascidian, Lissoclinum patella, also showed an apparent 
specificity towards Gram-positive bacteria.  This 
genus is known to contain the anti-bacterial compound 
Lissoclinotoxins (Litaudon et al., 1994).
Gram-positive bacteria tend to be more sensitive to drug 
action than Gram-negative bacteria (Cos et al., 2006; 
Malanovic & Lohner, 2016; Mcdonnell & Russell, 
1999)many of which have been used for hundreds of 
years, including alcohols, phenols, iodine, and chlorine. 
Most of these active agents demonstrate broad-spectrum 
antimicrobial activity; however, little is known about 
the mode of action of these agents in comparison to 
antibiotics. This review considers what is known about 
the mode of action and spectrum of activity of antiseptics 
and disinfectants. The widespread use of these products 
has prompted some speculation on the development of 
microbial resistance, in particular whether antibiotic 
resistance is induced by antiseptics or disinfectants. 
Known mechanisms of microbial resistance (both 
intrinsic and acquired. The former, such as S. aureus, 
are significant pathogens in hospital environments. For 
this reason, new anti-bacterial agents useful for treating 
serious Gram-positive infections are in demand.
Several cytotoxic compounds such as cyclic peptides, 
diterpenes, and alkaloids have been isolated from ascidian 
Lissoclinum patella and Didemnum molle (Donia et al., 
2008; Rashid et al., 1995; Sikorska, Hau, et al., 2012; 
Teruya et al., 2008). These compounds are cytotoxic 
against various tumor cell lines, and they are considered 
potential lead compounds for the development of new 
anticancer agents. 
The brine shrimp bioassay is broadly accepted as a useful 
indicator of potential cytotoxic activity in terrestrial 
plants and marine organisms. This assay, which has been 
shown to correlate well with cytotoxicity in cancer cell 
lines such as 9KB, P388, L5178Y and L1210 (De Rosa 
et al., 1994; Mclaughlin et al., 1998)to establish relevant 
structure-activity relationships (SAR, has the benefits 
of simplicity, low cost and reliability in assessing 
cytotoxicity. In our study that employed the assay, 
Lissoclinum patella and Didemnum molle were the most 
promising in their cytotoxic activity. 
CONCLUSION
Indonesian marine ascidians were shown to possess 
anti-microbial and cytotoxic activities. In our study, the 
most promising species for anti-microbial and cytotoxic 
properties were Lissoclinum patella and Didemnum 
molle. Extracts from these organisms will be further 
subjected to bioassay-guided fractionation to isolate the 
active compounds responsible for these properties of 
pharmacological relevance. 
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